Literature DB >> 1845898

Determinants of retrovirus gene expression in embryonal carcinoma cells.

E Akgün1, M Ziegler, M Grez.   

Abstract

The expression of Moloney murine leukemia virus is restricted in embryonal carcinoma (EC) cells. To characterize specific mutations necessary for expression of retroviruses in EC cells, we analyzed the expression of retrovirus mutants and recombinants thereof in EC cell lines F9 and PCC4. DNA sequence comparison and functional studies allowed us to define three point mutations in the enhancer region of the viral mutants at positions -345, -326, and -166 and two point mutations within the 5'-untranslated region of the viral genome at positions +164 and +165 that were essential for retrovirus expression in EC cells. DNA fragments derived from either the wild type or mutant viruses were used to search for sequence-specific DNA-binding factors in nuclear extracts from undifferentiated PCC4 cells. A cellular factor was found to bind strongly to sequences within the enhancer region (-354 to -306) of wild-type viruses but only weakly to sequences derived from mutant viruses. This factor was named ECF-I (for EC cell factor I). Retroviral expression in EC cells correlates with decreased binding affinity for ECF-I.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845898      PMCID: PMC240528     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia.

Authors:  S Strickland
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

2.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

3.  Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression.

Authors:  J W Gautsch; M C Wilson
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

4.  De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells.

Authors:  C L Stewart; H Stuhlmann; D Jähner; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  From embryo to teratocarcinoma in tissue culture.

Authors:  B Hogan
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

6.  Silent infection of murine embryonal carcinoma cells by Moloney murine leukemia virus.

Authors:  W C Speers; J W Gautsch; F J Dixon
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

7.  Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.

Authors:  A Stacey; C Arbuthnott; R Kollek; L Coggins; W Ostertag
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

Review 8.  Teratocarcinomas and mammalian embryogenesis.

Authors:  G R Martin
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

9.  Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice.

Authors:  W Ostertag; K Vehmeyer; B Fagg; I B Pragnell; W Paetz; M C Le Bousse; F Smadja-Joffe; B Klein; C Jasmin; H Eisen
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

10.  Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice.

Authors:  B Klein; C Le Bousse; B Fagg; F Smajda-Joffe; K Vehmeyer; K J Mori; C Jasmin; W Ostertag
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

View more
  22 in total

1.  Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4.

Authors:  C Modin; F S Pedersen; M Duch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Transgenic zebrafish produced by retroviral infection of in vitro-cultured sperm.

Authors:  Kayoko Kurita; Shawn M Burgess; Noriyoshi Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

Review 3.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

4.  Genomic rearrangements of retroviral vectors carrying two genes in F9 EC cells.

Authors:  B Breuer; B Steuer; A Alonso
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

5.  Self-deleting retrovirus vectors for gene therapy.

Authors:  A P Russ; C Friedel; M Grez; H von Melchner
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.

Authors:  C Laker; J Meyer; A Schopen; J Friel; C Heberlein; W Ostertag; C Stocking
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.

Authors:  C Baum; K Itoh; J Meyer; C Laker; Y Ito; W Ostertag
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.

Authors:  P B Robbins; D C Skelton; X J Yu; S Halene; E H Leonard; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Primer binding site-dependent restriction of murine leukemia virus requires HP1 binding by TRIM28.

Authors:  Daniel Wolf; Florence Cammas; Régine Losson; Stephen P Goff
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

10.  The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.

Authors:  Dennis L Haas; Carolyn Lutzko; Aaron C Logan; Gerald J Cho; Dianne Skelton; Xiao Jin Yu; Karen A Pepper; Donald B Kohn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.